Bishop NJ - Search Results

1

Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.

Arikoski P, Silverwood B, Tillmann V, Bishop NJ. Arikoski P, et al. Among authors: bishop nj. Bone. 2004 Mar;34(3):539-46. doi: 10.1016/j.bone.2003.11.019. Bone. 2004. PMID: 15003801

2

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.

Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Glorieux FH, et al. Among authors: bishop nj. N Engl J Med. 1998 Oct 1;339(14):947-52. doi: 10.1056/NEJM199810013391402. N Engl J Med. 1998. PMID: 9753709 Free article. Clinical Trial.

3

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age.

Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibis J, Travers R, Glorieux FH. Plotkin H, et al. Among authors: bishop nj. J Clin Endocrinol Metab. 2000 May;85(5):1846-50. doi: 10.1210/jcem.85.5.6584. J Clin Endocrinol Metab. 2000. PMID: 10843163 Clinical Trial.

4

Type V osteogenesis imperfecta: a new form of brittle bone disease.

Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ. Glorieux FH, et al. Among authors: bishop nj. J Bone Miner Res. 2000 Sep;15(9):1650-8. doi: 10.1359/jbmr.2000.15.9.1650. J Bone Miner Res. 2000. PMID: 10976985 Free article. Clinical Trial.

5

Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.

Tillmann V, Darlington AS, Eiser C, Bishop NJ, Davies HA. Tillmann V, et al. Among authors: bishop nj. J Bone Miner Res. 2002 Jun;17(6):1073-80. doi: 10.1359/jbmr.2002.17.6.1073. J Bone Miner Res. 2002. PMID: 12054163 Free article.

6

[Skeletal health during childhood and adolescence].

Arikoski P, Kröger L, Kröger H, Bishop NJ. Arikoski P, et al. Among authors: bishop nj. Duodecim. 2002;118(12):1251-7; quiz 1258, 1295. Duodecim. 2002. PMID: 12239815 Review. Finnish. No abstract available.

7

Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors.

Holmes SG, Still K, Buttle DJ, Bishop NJ, Grabowski PS. Holmes SG, et al. Among authors: bishop nj. Bone. 2004 Aug;35(2):471-8. doi: 10.1016/j.bone.2004.02.028. Bone. 2004. PMID: 15268899

8

Bisphosphonate treatment of bone disease.

Shaw NJ, Bishop NJ. Shaw NJ, et al. Among authors: bishop nj. Arch Dis Child. 2005 May;90(5):494-9. doi: 10.1136/adc.2003.036590. Arch Dis Child. 2005. PMID: 15851432 Free PMC article. Review.

9

Fractures and recurrent fractures in children; varying effects of environmental factors as well as bone size and mass.

Manias K, McCabe D, Bishop N. Manias K, et al. Bone. 2006 Sep;39(3):652-7. doi: 10.1016/j.bone.2006.03.018. Epub 2006 Jun 12. Bone. 2006. PMID: 16765659

10

Two doses of pamidronate in infants with osteogenesis imperfecta.

Senthilnathan S, Walker E, Bishop NJ. Senthilnathan S, et al. Among authors: bishop nj. Arch Dis Child. 2008 May;93(5):398-400. doi: 10.1136/adc.2007.125468. Epub 2007 Dec 18. Arch Dis Child. 2008. PMID: 18089634 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page